Date | Time | Source | Headline | Symbol | Company |
05/02/2024 | 2:07PM | iHub Newswire | FeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon | | |
05/01/2024 | 5:00PM | Business Wire | Novanta to Present at Baird's 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024 | NASDAQ:NOVT | Novanta Inc |
04/19/2024 | 3:48PM | Business Wire | Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024 | NASDAQ:NOVT | Novanta Inc |
04/09/2024 | 5:00PM | Business Wire | Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 7, 2024 | NASDAQ:NOVT | Novanta Inc |
03/05/2024 | 4:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
03/01/2024 | 5:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
03/01/2024 | 1:45PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:NOVT | Novanta Inc |
02/28/2024 | 4:40PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/28/2024 | 4:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/28/2024 | 4:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/28/2024 | 9:30AM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NOVT | Novanta Inc |
02/28/2024 | 8:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NOVT | Novanta Inc |
02/28/2024 | 6:59AM | Business Wire | Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023 | NASDAQ:NOVT | Novanta Inc |
02/23/2024 | 6:57PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/23/2024 | 6:55PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/23/2024 | 6:51PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/23/2024 | 6:49PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/23/2024 | 6:45PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/22/2024 | 6:05PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/22/2024 | 6:01PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/22/2024 | 5:55PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/09/2024 | 4:34PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
02/05/2024 | 4:34PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
01/29/2024 | 5:00PM | Business Wire | Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, February 28, 2024 | NASDAQ:NOVT | Novanta Inc |
01/04/2024 | 4:58PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
01/04/2024 | 4:55PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
01/04/2024 | 4:53PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
01/04/2024 | 4:51PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
01/04/2024 | 4:49PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |
01/04/2024 | 4:48PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NOVT | Novanta Inc |